First Affiliated Hospital of Chongqing Medical University Report issue

Academic/Hospital Phase 4

Organization Overview

First Clinical Trial
2016
NCT02576015
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2017

Timeline

NOW
  • Now

Alternative names

Min Su

Active Ingredients

Drugs in Phase 4 Trials (1)

dexmedetomidine (precedex) (1 trial)

Drugs in Other Trials (4)

insulin human (humulin) (1 trial)

lidocaine (xylocaine) (1 trial)

ropivacaine (naropin) (1 trial)

sodium chloride (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Thyroid Diseases (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 2
  • # of Trial APIs: 5